Global Echocardiography (ECG) Devices Market Research Report 2019 (Includes Business Impact of COVID-19)

                                          
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Echocardiography (ECG) Devices market.

Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Echocardiography (ECG) Devices market."
ECG is a process of recording the electrical signals associated with cardiac activity over a period of time. It has become a routine part of any medical evaluation and has been used as a diagnostic test in the past seven decades. ECG is used for the diagnosis and treatment of various types of heart conditions such as myocardial infarctions (heart attacks) and arrhythmias (abnormal heart rhythms). ECG is a non-invasive procedure used for the diagnosis of heart conditions. The rising incidences of CVDs have led to the rise in the use of ECG devices. The ECG devices market is further segmented into resting ECGs, stress testing, cardiopulmonary stress testing, and Holter monitoring systems. 
Hypertension is the most common cause of heart failure and is caused due to a rise in blood pressure in the arteries. These health risks mainly arise because of unhealthy dietary habits, increased stress, and lack of physical activity due to hectic lifestyles. As observed by experts, the primary reason responsible for the majority of cardiac disorders is hypertension. In the US, the incidences of cardiovascular diseases (CVDs), such as coronary heart disease (CHD), stroke, and heart attack are increasing. These chronic diseases require diagnosis and treatment to monitor the severity of the patients medical condition daily and maintain medical health records. Moreover, the growing hospitalization of the older population for the treatment of cardiac diseases has also increased the need for ECG diagnosis, which in turn, is expected to propel the growth of the global ECG devices market during the forecast period.
The global echocardiography (ECG) devices market will grow steadily at a CAGR of above 5.8% by 2022. The global ECG devices market is highly fragmented due to the presence of several international and regional players. As a result, vendors adopt various strategies and competitive pricing to sustain themselves in the market and increase their shares. Technological advancements are one of the key focus areas of a majority of international players. The competitive environment in this market is anticipated to intensify with an increase in technological innovations, product extensions, and increase in M&As.

The global Echocardiography (ECG) Devices market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Echocardiography (ECG) Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Echocardiography (ECG) Devices market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    GE Healthcare
    Hill-Rom
    NIHON KOHDEN
    Philips Healthcare
    Schiller
    Spacelabs Healthcare
    AliveCor
    Allengers
    AMEDTEC Medizintechnik Aue
    Applied Cardiac Systems
    ASPEL
    Beurer
    Biocare Bio-Medical Equipment
    Bionet
    Bionym (now Nymi)
    Cardiac Designs
    Cardinal Health
    CardioComm Solutions
    Cardioline
    CardioSecur
    Edan Instruments
    DMS Service
    DailyCare BioMedical
    Fukuda Denshi
    InfoBionic
    iRhythm Technologies
    Kalamed
    Medicomp
    MGC Diagnostics
    Midmark
    Nasiff Associates
    Planexta
    Qardio
    QRS Diagnostic
    REKA Health
    SunTech Medical
    Tenko International
    Zoncare Bio-Medical

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    Resting ECG devices
    Stress ECG devices
    Holter monitoring devices
    Cardiopulmonary stress testing devices

Segment by Application
    Hospitals
    Diagnostic centers
    ASCs